{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:33Z","timestamp":1792664613181,"version":"4.5.0"},"reference-count":84,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Cutaneous leishmaniasis (CL) is a vector-borne infection caused by protozoan parasites belonging to the genus Leishmania. CL is an emerging global health concern due to increasing migration, travel, and climate change. Traditionally, it was confined to endemic regions such as the Americas, the Middle East, and Central Asia; however, it is now spreading to non-endemic areas. Climate change has further contributed to the expansion of sandfly habitats, increasing CL transmission risk in previously unaffected areas. Healthcare providers in non-endemic regions often misdiagnose CL, delaying treatment and morbidity. Diagnosis remains challenging due to the need for species-specific identification, while treatment is limited by cost, availability, and personnel expertise. This review explores the epidemiology, clinical presentation, diagnostic challenges, and management of CL in the context of global mobility. It highlights rising CL cases in refugee settlements, particularly in Lebanon and Jordan, due to poor living conditions, inadequate vector control, and healthcare barriers. While there have been advances in systemic and topical therapies, access in refugee and resource-poor settings remains a barrier. Addressing the global burden of CL requires improved surveillance, healthcare provider training, and increased awareness. By enhancing global collaboration and policy changes, public health efforts can mitigate the expanding impact of CL.<\/jats:p>","DOI":"10.3390\/clinpract15040077","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:46:20Z","timestamp":1744274780000},"page":"77","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises"],"prefix":"10.3390","volume":"15","author":[{"given":"Janice","family":"Kim","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Zieneldien","sequence":"additional","affiliation":[{"name":"School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard A.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins Hospital, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasit Vectors"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cec\u00edlio, P., Cordeiro-da-Silva, A., and Oliveira, F. (2022). Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03240-z"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cosma, C., Maia, C., Khan, N., Infantino, M., and Del Riccio, M. (2024). Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9110258"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100183","DOI":"10.1016\/j.jmh.2023.100183","article-title":"Dermatologic conditions of adult refugees following resettlement in the United States, 2015 to 2018","volume":"7","author":"Ching","year":"2023","journal-title":"J. Migr. Health"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Du, R., Hotez, P.J., Al-Salem, W.S., and Acosta-Serrano, A. (2016). Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004545"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.36519\/idcm.2023.202","article-title":"An Update on the Imported Cutaneous Leishmaniasis in Europe","volume":"5","author":"Kurt","year":"2023","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"taae051","DOI":"10.1093\/jtm\/taae051","article-title":"Surge in imported cutaneous leishmaniasis cases from Mexico in 2023: A case series","volume":"31","author":"Lindner","year":"2024","journal-title":"J. Travel Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Curtin, J.M., and Aronson, N.E. (2021). Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030578"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e14439","DOI":"10.2196\/14439","article-title":"Trend of Cutaneous Leishmaniasis in Jordan from 2010 to 2016: Retrospective Study","volume":"6","author":"Alhawarat","year":"2020","journal-title":"JMIR Public Health Surveill."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s11686-021-00395-3","article-title":"The Association Between the Syrian Crisis and Cutaneous Leishmaniasis in Lebanon","volume":"66","author":"Bizri","year":"2021","journal-title":"Acta Parasitol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3201\/eid2010.140288","article-title":"Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon","volume":"20","author":"Saroufim","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3201\/eid2205.160042","article-title":"Cutaneous Leishmaniasis and Conflict in Syria","volume":"22","author":"Pigott","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/trstmh\/trt119","article-title":"The emergence of Leishmania major and Leishmania donovani in southern Turkey","volume":"108","author":"Koltas","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10900-009-9175-3","article-title":"Healthcare barriers of refugees post-resettlement","volume":"34","author":"Morris","year":"2009","journal-title":"J. Community Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40794-022-00175-5","article-title":"Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: A case report","volume":"8","author":"Sikorska","year":"2022","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"taaa161","DOI":"10.1093\/jtm\/taaa161","article-title":"Cutaneous leishmaniasis in refugees from Syria: Complex cases in Berlin 2015\u20132020","volume":"27","author":"Lindner","year":"2020","journal-title":"J. Travel Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2230.2004.01605.x","article-title":"The psychological impact of cutaneous leishmaniasis","volume":"29","author":"Yanik","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.det.2020.08.010","article-title":"Challenges of Managing Skin Diseases in Refugees and Migrants","volume":"39","author":"Padovese","year":"2021","journal-title":"Dermatol. Clin."},{"key":"ref_19","unstructured":"(2025, March 03). Refugees UNHCf: Refugee Statistics. Available online: https:\/\/www.unrefugees.org\/refugee-facts\/statistics\/#:~:text=By%20May%202024%2C%20more%20than,63.3%20million%20internally%20displaced%20people."},{"key":"ref_20","unstructured":"(2025, March 03). UNHCR Uf: Refugee Camps Explained. Available online: https:\/\/www.unrefugees.org\/refugee-facts\/camps\/?SF_monthly=7011K000001HH7WQAW?SF_monthly."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s13555-022-00823-w","article-title":"The Impact of Global Health Disparities on Atopic Dermatitis in Displaced Populations: Narrowing the Health Equity Gap for Patients with Skin of Color","volume":"12","author":"Jelousi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(05)61027-6","article-title":"Prevalence of serious mental disorder in 7000 refugees resettled in western countries: A systematic review","volume":"365","author":"Fazel","year":"2005","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.170.4.351","article-title":"Anxiety, depression and PTSD in asylum-seekers: Assocations with pre-migration trauma and post-migration stressors","volume":"170","author":"Silove","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11920-016-0723-0","article-title":"The Relationship Between Post-Migration Stress and Psychological Disorders in Refugees and Asylum Seekers","volume":"18","author":"Li","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0923-1811(97)00074-1","article-title":"The relationship between the psychological and immunological state in patients with atopic dermatitis","volume":"16","author":"Hashiro","year":"1998","journal-title":"J. Dermatol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2005.06449.x","article-title":"Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis","volume":"152","author":"Hashizume","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jdv.15909","article-title":"Skin disease profile of Syrian refugees in Jordan: A field-mission assessment","volume":"34","author":"Saikal","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/ijd.14619","article-title":"Skin diseases in rural Nyala, Sudan (in a rural hospital, in 12 orphanages, and in two refugee camps)","volume":"58","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/hex.13365","article-title":"Improving primary health care quality for refugees and asylum seekers: A systematic review of interventional approaches","volume":"25","author":"Iqbal","year":"2022","journal-title":"Health Expect."},{"key":"ref_30","unstructured":"United Nations High Commissioner for Refugees (2020). Health in Camps. UNHCR Emergency Handbook, United Nations High Commissioner for Refugees. Available online: https:\/\/emergency.unhcr.org\/emergency-assistance\/health-and-nutrition\/health-care-contexts\/health-camps-and-settlements."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/tmi.13552","article-title":"Addressing the challenges to skin health of refugees and migrants in the WHO European region","volume":"26","author":"Bartovic","year":"2021","journal-title":"Trop. Med. Int. Health"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ekemen, S., Nalcaci, M., Toz, S., Sanjoba, C., Demirkesen, C., Cetin, E.D., Tecimer, T., Yildiz, P., Gursel, M., and Ince, U. (2024). Diagnostic challenges in cutaneous leishmaniasis due to atypical Leishmania infantum: Pathologists\u2019 insights from re-emergence zones. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1453211"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Riebenbauer, K., Czerny, S., Egg, M., Urban, N., Kinaciyan, T., Hampel, A., Fidelsberger, L., Karlhofer, F., Porkert, S., and Walochnik, J. (2024). The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0011875"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/ijd.15543","article-title":"Climate change, human migration, and skin disease: Is there a link?","volume":"61","author":"Dayrit","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, C., Wang, O., Strutz, S.E., Gonz\u00e1lez-Salazar, C., S\u00e1nchez-Cordero, V., and Sarkar, S. (2010). Climate change and risk of leishmaniasis in north america: Predictions from ecological niche models of vector and reservoir species. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000585"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/reveh-2015-0013","article-title":"Climate change and health in the Eastern Mediterranean countries: A systematic review","volume":"30","author":"Khader","year":"2015","journal-title":"Rev. Environ. Health"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Senanayake, S.C., Liyanage, P., Pathirage, D.R.K., Siraj, M.F.R., De Silva, B., and Karunaweera, N.D. (2024). Impact of climate and land use on the temporal variability of sand fly density in Sri Lanka: A 2-year longitudinal study. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012675"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s11686-022-00533-5","article-title":"Climate Change Influences on the Potential Distribution of the Sand Fly Phlebotomus sergenti, Vector of Leishmania tropica in Morocco","volume":"67","author":"Daoudi","year":"2022","journal-title":"Acta Parasitol."},{"key":"ref_39","unstructured":"Maxfield, L., and Crane, J.S. (2025). Leishmaniasis. StatPearls, StatPearls Publishing LLC."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Carneiro, M.B., and Peters, N.C. (2021). The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-Leishmania amazonensis Interactions Lead to a Progressive Chronic Disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.728848"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Volpedo, G., Pacheco-Fernandez, T., Holcomb, E.A., Cipriano, N., Cox, B., and Satoskar, A.R. (2021). Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis and Post Kala-azar Dermal Leishmaniasis (PKDL). Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.685296"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Scorza, B.M., Carvalho, E.M., and Wilson, M.E. (2017). Cutaneous Manifestations of Human and Murine Leishmaniasis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061296"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00004714-199510000-00003","article-title":"Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam","volume":"15","author":"Barbhaiya","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: Clinical syndromes and treatment","volume":"107","author":"McGwire","year":"2014","journal-title":"QJM"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.abd.2021.03.003","article-title":"Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis","volume":"96","author":"Sampaio","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actatropica.2004.06.006","article-title":"Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients","volume":"92","author":"Amato","year":"2004","journal-title":"Acta Trop."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/trstmh\/trz037","article-title":"What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil","volume":"113","author":"Silveira","year":"2019","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Christensen, S.M., Belew, A.T., El-Sayed, N.M., Tafuri, W.L., Silveira, F.T., and Mosser, D.M. (2019). Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007152"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"da Silva, R.L., Elizondo, D.M., Brandy, N.Z.D., Haddock, N.L., Boddie, T.A., de Oliveira, L.L., de Jesus, A.R., de Almeida, R.P., de Moura, T.R., and Lipscomb, M.W. (2021). Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses. Sci. Rep., 11.","DOI":"10.1038\/s41598-020-79068-6"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Novais, F.O., Amorim, C.F., and Scott, P. (2021). Host-Directed Therapies for Cutaneous Leishmaniasis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.660183"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104855","DOI":"10.1016\/j.actatropica.2018.12.010","article-title":"Leishmania infection: Misdiagnosis as cancer and tumor-promoting potential","volume":"197","author":"Schwing","year":"2019","journal-title":"Acta Trop."},{"key":"ref_52","first-page":"352","article-title":"Leishmaniasis\u2014Still a diagnostic challenge: An individual participant data systematic review","volume":"54","author":"Sarfraz","year":"2024","journal-title":"Trop. Dr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments","volume":"23","author":"Schallig","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/jphe-24-51","article-title":"Diagnostic advances in tegumentary leishmaniasis: A narrative review from 2018 to 2023","volume":"8","author":"Palma","year":"2024","journal-title":"J. Publich Health Emerg."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hodiamont, C.J., Kager, P.A., Bart, A., de Vries, H.J., van Thiel, P.P., Leenstra, T., de Vries, P.J., van Vugt, M., Grobusch, M.P., and van Gool, T. (2014). Species-directed therapy for leishmaniasis in returning travellers: A comprehensive guide. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002832"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13071-022-05524-z","article-title":"Laboratory diagnostics for human Leishmania infections: A polymerase chain reaction-focussed review of detection and identification methods","volume":"15","author":"Gow","year":"2022","journal-title":"Parasit Vectors"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/labmed\/lmac134","article-title":"Review of the Clinical Presentation, Pathology, Diagnosis, and Treatment of Leishmaniasis","volume":"54","author":"Mathison","year":"2023","journal-title":"Lab. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Talimi, H., Retmi, K., Fissoune, R., and Lemrani, M. (2024). Artificial Intelligence in Cutaneous Leishmaniasis Diagnosis: Current Developments and Future Perspectives. Diagnostics, 14.","DOI":"10.3390\/diagnostics14090963"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","first-page":"11","article-title":"Lipsosomal amphotericin B: A review of its properties, function, and use for treatment of cutaneous leishmaniasis","volume":"10","author":"Shirzadi","year":"2019","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wasan, K.M. (2024). Development and deployment of a solid oral amphotericin B dosage form to treat visceral leishmaniasis within a pediatric population. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012500"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Castro, M.D.M., Rode, J., Machado, P.R.L., Llanos-Cuentas, A., Hueb, M., Cota, G., Rojas, I.V., Orobio, Y., Oviedo Sarmiento, O., and Rojas, E. (2023). Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011029"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/abbi.1998.0695","article-title":"Tungstate: A potent inhibitor of multifunctional glucose-6-phosphatase","volume":"354","author":"Foster","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2018.05.007","article-title":"Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies","volume":"14","author":"Shokri","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/ijd.14002","article-title":"Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey","volume":"57","author":"Uzun","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Azim, M., Khan, S.A., Ullah, S., Ullah, S., and Anjum, S.I. (2021). Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009099"},{"key":"ref_68","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: Double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"Asilian","year":"2003","journal-title":"Bull. World Health Organ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review","volume":"11","author":"Madusanka","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Machado, P.R., Ampuero, J., Guimar\u00e3es, L.H., Villasboas, L., Rocha, A.T., Schriefer, A., Sousa, R.S., Talhari, A., Penna, G., and Carvalho, E.M. (2010). Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: A randomized and controlled trial. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000912"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1093\/cid\/ciaa1238","article-title":"Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis","volume":"73","author":"Ware","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e01614-17","DOI":"10.1128\/AAC.01614-17","article-title":"Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel","volume":"62","author":"Benaim","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kima, P.E., and Soong, L. (2013). Interferon gamma in leishmaniasis. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00156"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania Vaccines: The Current Situation with Its Promising Aspect for the Future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J. Parasitol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lafleur, A., Daffis, S., Mowbray, C., and Arana, B. (2024). Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis. Vaccines, 12.","DOI":"10.3390\/vaccines12101179"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1000238","article-title":"Applying TLR synergy in immunotherapy: Implications in cutaneous leishmaniasis","volume":"185","author":"Raman","year":"2010","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamadermatol.2018.2133","article-title":"Incidence of Endemic Human Cutaneous Leishmaniasis in the United States","volume":"154","author":"McIlwee","year":"2018","journal-title":"JAMA Dermatol"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A Review of Leishmaniasis: Current Knowledge and Future Directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_80","unstructured":"(2025, March 03). E-Learning: Social Lessons from an Online Course on Cutaneous Leishmaniasis. Available online: https:\/\/www.who.int\/news\/item\/07-03-2019-e-learning-social-lessons-from-an-online-course-on-cutaneous-leishmaniasis."},{"key":"ref_81","unstructured":"(2025, March 03). WHO Designates New Collaborating Centre for Case Management of Cutaneous Leishmaniasis in Tunisia. Available online: https:\/\/www.emro.who.int\/neglected-tropical-diseases\/ntd-news\/new-collaborating-centre-for-cutaneous-leishmaniasis-case-management-in-tunisia.html#:~:text=29%20November%202020%20%E2%80%93%20The%20World,cutaneous%20leishmaniasis%2C%20valid%20until%202023."},{"key":"ref_82","unstructured":"(2025, March 03). Ending the Neglect to Attain the Sustainable Development Goals: A Strategic Framework for Integrated Control and Management of Skin-Related Neglected Tropical Diseases. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240051423."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Castillo, M., Alexander, N., Rubiano, L., Rojas, C., Navarro, A., Rincon, D., Bernal, L.V., Lerma, Y.O., Saravia, N.G., and Aronoff-Spencer, E. (2023). Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia. PLoS Negl. Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011180"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Polidano, K., Parton, L., Agampodi, S.B., Agampodi, T.C., Haileselassie, B.H., Lalani, J.M.G., Mota, C., Price, H.P., Rodrigues, S., and Tafere, G.R. (2022). Community Engagement in Cutaneous Leishmaniasis Research in Brazil, Ethiopia, and Sri Lanka: A Decolonial Approach for Global Health. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.823844"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/4\/77\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:30Z","timestamp":1760029950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/4\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["clinpract15040077"],"URL":"https:\/\/doi.org\/10.3390\/clinpract15040077","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}